首页> 外文期刊>Journal of Clinical Microbiology >Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.
【24h】

Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.

机译:间接血凝测定法可诊断溶血尿毒症综合征患者的大肠杆菌O157感染。

获取原文
           

摘要

An indirect hemagglutination assay consisting of sheep erythrocytes coated with lipopolysaccharide (LPS) from Shiga-like toxin-producing Escherichia coli O157 was used for the serological diagnosis of E. coli O157 infections in children with classical (enteropathic) hemolytic-uremic syndrome (HUS). One week after the onset of diarrhea (acute phase of the disease), the E. coli O157 antibody titer was greater than or equal to 1:4,096 in 22 of 27 patients with HUS, compared with 4 of 249 controls, the majority of whom had O157 antibody titers of between 1:4 and 1:256. This antibody response was observed in HUS patients with stool cultures positive and negative for E. coli O157. Selective absorption with homologous LPS and heterologous LPS showed that the antibody response was specific for E. coli O157. Because of its simplicity and ease of interpretation, the indirect hemagglutination assay described in this paper is recommended for the serological diagnosis of E. coli O157 infections in patients with HUS.
机译:间接血凝测定法由羊血红细胞组成,羊血红细胞涂有滋贺样毒素产生性大肠杆菌O157的脂多糖(LPS),被用于血清学诊断患有经典(肠病)溶血性尿毒症综合征(HUS)的儿童的大肠杆菌O157感染。腹泻(疾病的急性期)发作一周后,在27例HUS患者中,有22例HUS患者的大肠杆菌O157抗体滴度大于或等于1:4,096,而在249例对照中,有4例具有的O157抗体效价在1:4和1:256之间。在粪便培养物中大肠杆菌O157阳性和阴性的HUS患者中观察到该抗体反应。同源LPS和异源LPS的选择性吸收表明抗体应答对大肠杆菌O157具有特异性。由于其简便易懂,因此建议将本文所述的间接血凝测定法用于HUS患者的大肠杆菌O157感染的血清学诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号